Cart
sales@molnova.com
Higenamine
CAS No. 5843-65-2
Higenamine ( Demethyl-Coclaurine )
Catalog No. M19818 CAS No. 5843-65-2
Higenamine is a novel α1 -adrenoceptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 95 | In Stock |
|
| 25MG | 163 | In Stock |
|
| 50MG | 281 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHigenamine
-
NoteResearch use only not for human use.
-
Brief DescriptionHigenamine is a novel α1 -adrenoceptor antagonist.
-
DescriptionHigenamine is a novel α1 -adrenoceptor antagonist.
-
SynonymsDemethyl-Coclaurine
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptorα1-adrenergic receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5843-65-2
-
Formula Weight271.31
-
Molecular FormulaC16H17NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESOc1ccc(CC2NCCc3cc(O)c(O)cc23)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang N et al. Identification of higenamine as a novel α1 -adrenergic receptor antagonist. Phytother Res. 2019 Jan 15.
molnova catalog
related products
-
ICI 89406
ICI 89406 is a β-adrenergic antagonist.
-
Acebutolol hydrochlo...
A cardioselective beta blocker for the treatment of hypertension and arrhythmias.
-
Dabuzalgron
Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.
